Sponsored by Lane Powell

Pfizer results beat estimates

| Print |  Email
Tuesday, July 29, 2014

WSJ: The pharmaceutical giant posted earnings of $2.91 billion, or 45 cents per share.

Revenue decreased 1.5% to $12.77 billion, hurt by foreign currency changes and the expiration of the co-promotion term for Enbrel, a psoriasis and rheumatoid arthritis drug.

Analysts had projected per-share earnings of 57 cents and revenue of $12.47 billion.

Research and development spending rose 13% to $1.71 billion.

Read more here.

 

More Articles

Oregon Business expands events portfolio

The Latest
Friday, March 27, 2015
htctfacebookBY OB STAFF

New events series brings magazine to life.


Read more...

The Health Guru

May 2015
Monday, April 27, 2015
BY LINDA BAKER

Mohan Nair channels a visionary.


Read more...

Epitaph for a Boondoggle

April 2015
Friday, March 27, 2015
BY JOE CORTRIGHT

The CRC is a cautionary tale about how we plan for, finance and invest in transportation infrastructure.


Read more...

City announces plans for Portland summer-league baseball team

News
Tuesday, March 10, 2015
IMG 3888BY JACOB PALMER | OB DIGITAL NEWS EDITOR

Baseball is returning to Portland and city officials are hoping economic opportunity comes with it.


Read more...

Shades of Gray

May 2015
Monday, April 27, 2015
BY KIM MOORE

Are we too quick to diagnose corruption?


Read more...

Banking Perspective

April 2015
Thursday, March 26, 2015
BY KIM MOORE

A conversation with Craig Wanichek, president and CEO of Summit Bank.


Read more...

Downtime with the director of Barley's Angels

May 2015
Monday, April 27, 2015
BY JACOB PALMER

Live, Work, Play with Christine Jump.


Read more...
Oregon Business magazinetitle-sponsored-links-02
SPONSORED LINKS